Recent Articles from The Motley Fool
The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
Website: https://www.fool.com
Two hedge fund managers bought Micron and sold Nvidia in the fourth quarter, but investors should think twice before making the same trade.
Via The Motley Fool · March 17, 2026
Alphabet's cash-rich balance sheet is allowing one of Wall Street's most-loved companies to aggressively invest in itself.
Via The Motley Fool · March 17, 2026
These blunders could have a serious impact on your retirement finances.
Via The Motley Fool · March 17, 2026
Berkshire Hathaway shareholders should be reassured by Greg Abel's early moves as the new CEO.
Via The Motley Fool · March 17, 2026
If international dividend stocks keep up their strong annual returns, this ETF could make you a stock market millionaire.
Via The Motley Fool · March 17, 2026
With the year almost 25% over, investors are figuring out ways to reposition their portfolios.
Via The Motley Fool · March 17, 2026
Is there an AI bubble primed to pop? Who's to say? But these two stocks should help you hedge against it either way.
Via The Motley Fool · March 17, 2026
Inflation remains elevated, while unemployment has risen and growth has slowed.
Via The Motley Fool · March 17, 2026
These are elite retail businesses that can help you build wealth.
Via The Motley Fool · March 17, 2026
If you think you've already seen every worthwhile income play in energy, you're probably missing where some of the biggest yields are hiding. Three high-paying partnerships aim to deliver 7% to 10%+ distributions with business models designed to hold up across commodity cycles.
Via The Motley Fool · March 17, 2026
Stay invested through sharp swings and avoid panic moves by focusing on long-term fundamentals.
Via The Motley Fool · March 17, 2026
Ethereum has seen its price plummet, but it remains one of the most important blockchains.
Via The Motley Fool · March 17, 2026
Pfizer has reached a turning point.
Via The Motley Fool · March 17, 2026

These stocks can make for great core holdings.
Via The Motley Fool · March 17, 2026

Motorsport Games (MSGM) Earnings Call Transcript
Via The Motley Fool · March 17, 2026

KinderCare (KLC) Q4 2025 Earnings Call Transcript
Via The Motley Fool · March 17, 2026
Nvidia and Microsoft are screaming deals right now.
Via The Motley Fool · March 17, 2026
The social media platform's underlying business is surging, and the stock's recent sell-off might be giving investors an attractive entry point.
Via The Motley Fool · March 17, 2026
Shares of Lucid have fallen 98% from their peak, which some may see as an opportunity, even though it also highlights material risk.
Via The Motley Fool · March 16, 2026
Both Alphabet and Palantir are riding a massive wave of artificial intelligence demand, but a closer look at the two reveals a stark difference in their investment potential.
Via The Motley Fool · March 16, 2026
Defense spending is on the rise around the world, and these two companies are set for some serious growth because of it.
Via The Motley Fool · March 16, 2026

Tesla sells cars -- and the auto industry is notoriously cyclical. But Tesla's structure and long-term strategy may give it more resilience than its peers.
Via The Motley Fool · March 16, 2026
Oil pushing toward $100 can make energy dividends look irresistible, but the best picks are the ones that don't need $100 oil to keep paying you. Here are two dividend giants that have already proven their payouts can hold up when the cycle turns.
Via The Motley Fool · March 16, 2026
These companies boast strong sales and compelling share price valuations.
Via The Motley Fool · March 16, 2026
My top three TSX stocks form a fortress-like portfolio capable of weathering the geopolitical storm in 2026.
Via The Motley Fool · March 16, 2026
Oil prices go up, and they go down; these high-yield energy businesses don't really care.
Via The Motley Fool · March 16, 2026
These two high-yielding dividend stocks might be excellent additions to your self-directed portfolio for passive income.
Via The Motley Fool · March 16, 2026
Nvidia is riding a multiyear demand wave.
Via The Motley Fool · March 16, 2026
Yellow Pages (TSX:Y) is a top Canadian dividend stock that many investors focus on for its yield, but that could be a dangerous move right now.
Via The Motley Fool · March 16, 2026

Amazon's stock behavior differed greatly from CrowdStrike's reaction to its 2024 outage.
Via The Motley Fool · March 16, 2026
A blockbuster deal with an artificial intelligence (AI) giant has investors excited.
Via The Motley Fool · March 16, 2026
Canopy Growth Corp (TSX:WEED) could wreck your portfolio.
Via The Motley Fool · March 16, 2026
Add this TSX stock to your self-directed investment portfolio if you’re on the hunt for growth stocks in this market environment.
Via The Motley Fool · March 16, 2026
These two monster Canadian stocks look like screaming buys for investors looking for not only recent momentum, but long-term total upside potential.
Via The Motley Fool · March 16, 2026
While both of these iconic consumer brands offer dividends, one stands out as the better buy today.
Via The Motley Fool · March 16, 2026

Invesco DWA Momentum ETF tracks a diversified portfolio of U.S. equities selected for strong relative strength characteristics.
Via The Motley Fool · March 16, 2026

This technology ETF tracks the NASDAQ-100 sector with an equal-weighted strategy, offering diversified exposure to large-cap tech equities.
Via The Motley Fool · March 16, 2026
I'm surprised this bank is still around, much less paying a 4.66% dividend yield.
Via The Motley Fool · March 16, 2026

Oracle has guided for tremendous revenue growth in its cloud infrastructure business over its next four fiscal years.
Via The Motley Fool · March 16, 2026
A $3,000 capital investment can buy the top Canadian stocks and create a mini-portfolio in 2026.
Via The Motley Fool · March 16, 2026
Some stocks can perform well even during a recession.
Via The Motley Fool · March 16, 2026

Nuvalent develops targeted therapies for drug-resistant cancers, advancing clinical-stage candidates in precision oncology.
Via The Motley Fool · March 16, 2026
The company recently unveiled its R2 lineup.
Via The Motley Fool · March 16, 2026

nLIGHT, a leader in advanced laser solutions for industry and defense, just reported a notable insider sale amid standout 1-year returns.
Via The Motley Fool · March 16, 2026

This clinical-stage biotech develops small-molecule therapies targeting NASH, obesity, and related metabolic diseases.
Via The Motley Fool · March 16, 2026
Seniors get a generous new tax deduction, but there's only a limited time to claim it.
Via The Motley Fool · March 16, 2026
Long-term dividend investors can take advantage of a rare combination of essential assets, a global footprint, and a steadily growing distribution in this stable stock.
Via The Motley Fool · March 16, 2026
Capstone Copper, VitalHub, and Electrovaya are profitable, fast-growing TSX stocks riding copper demand, healthcare tech, and the AI battery boom.
Via The Motley Fool · March 16, 2026
CoreWeave is posting incredible top-line growth, but its staggering costs and capital requirements make the stock too speculative for my portfolio.
Via The Motley Fool · March 16, 2026

This biotech develops Nanobody-based therapies targeting chronic inflammatory diseases in dermatology and rheumatology markets.
Via The Motley Fool · March 16, 2026
Impressed by the take-up of the company's stablecoin, an analyst upgraded his recommendation to buy.
Via The Motley Fool · March 16, 2026
Reliable dividend payers, like this regulated utility and this diversified financial, can keep cash coming in while the market sorts itself out.
Via The Motley Fool · March 16, 2026
Nebius Group has emerged as a key player fueling AI infrastructure.
Via The Motley Fool · March 16, 2026
Intel stock swung dramatically on Monday.
Via The Motley Fool · March 16, 2026

Arcellx develops cell-based immunotherapies for cancer, leveraging proprietary platforms to address high unmet needs in oncology.
Via The Motley Fool · March 16, 2026
An analyst raised his price target on the beleaguered tech stock.
Via The Motley Fool · March 16, 2026
These beaten-down retail stocks could begin to grow on improved business performance and low valuations.
Via The Motley Fool · March 16, 2026
Competition has been intensifying in the electric vehicle market, and that has resulted in some lackluster results for Tesla in recent quarters.
Via The Motley Fool · March 16, 2026
It's smart for investors to consider ways to build their portfolios with exposure to AI.
Via The Motley Fool · March 16, 2026
AI data centers have a need for speed.
Via The Motley Fool · March 16, 2026
Nvidia's GTC conference delivered big news, but the stock couldn't hold onto its early gains.
Via The Motley Fool · March 16, 2026
Devon Energy is quietly building one of the most durable shareholder-return stories in U.S. shale: ultra-low production costs, billions in free cash flow, and a pending Coterra merger that could lift the dividend and supercharge buyback.
Via The Motley Fool · March 16, 2026
Ethereum believers should take a look at this stock.
Via The Motley Fool · March 16, 2026

Kaltura (KLTR) Q4 2025 Earnings Call Transcript
Via The Motley Fool · March 16, 2026

Olema Pharmaceuticals develops targeted therapies for women's cancers, with a lead candidate in clinical trials for breast cancer treatment.
Via The Motley Fool · March 16, 2026
Both of these Canadian Bank ETFs employ leverage and covered calls to deliver 10-14% yields.
Via The Motley Fool · March 16, 2026

Today, March 16, 2026, investors weigh striking early colorectal cancer results against weak quarterly numbers and a finite cash runway.
Via The Motley Fool · March 16, 2026

Praxis Precision Medicines develops clinical-stage therapies for neurological disorders, targeting major unmet needs in CNS therapeutics.
Via The Motley Fool · March 16, 2026
The AI chipmaker kicked off its annual developer conference with a bang.
Via The Motley Fool · March 16, 2026

With similar costs but differences in size, sector focus, and liquidity, these ETFs offer distinct advantages for small-cap investors.
Via The Motley Fool · March 16, 2026

SoundHound AI rose after unveiling its Edge Agentic+ automotive assistant at Nvidia’s GTC conference, as investors assess how on-device AI could expand voice software adoption in vehicles.
Via The Motley Fool · March 16, 2026
There were 300 million reasons for this.
Via The Motley Fool · March 16, 2026
The S&P 500 Shiller CAPE ratio is at its highest level in more than two decades.
Via The Motley Fool · March 16, 2026
Shiba Inu has been gaining even as the stock market has been falling.
Via The Motley Fool · March 16, 2026

DocGo (DCGO) Q4 2025 Earnings Call Transcript
Via The Motley Fool · March 16, 2026